December 29, 2014 11:55 AM ET

Pharmaceuticals

Company Overview of St. Charles Pharmaceuticals, Inc.

Company Overview

St. Charles Pharmaceuticals, Inc. develops pharmaceutical therapies for pain and neuroprotection markets. It offers its products/therapies for acute pain, neuropathic, post operation, chronic, synergy with opioids, analogs, neuro-inflammation, and neuroprotection conditions. The company is based in New Orleans, Louisiana.

2020 Gravier Street

New Orleans, LA 70112

United States

Phone:

504-568-8542

Key Executives for St. Charles Pharmaceuticals, Inc.

Co-Founder and Director
Age: 71
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Encore Pharmaceuticals, Inc. United States
Valley Nuclear Incorporated United States
Protherics Salt Lake City, Inc. United States
Avidas Pharmaceuticals LLC United States
ABH Nature's Products, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact St. Charles Pharmaceuticals, Inc., please visit www.stcharlespharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.